Codiak BioSciences Inc (CDAK)

NASDAQ
0.74
+0.02(+2.78%)
After Hours
0.74
0.00(0.00%)
- Real-time Data
  • Volume:
    23,198
  • Day's Range:
    0.73 - 0.75
  • 52 wk Range:
    0.59 - 15.08

CDAK Overview

Prev. Close
0.72
Day's Range
0.73-0.75
Revenue
34.07M
Open
0.75
52 wk Range
0.59-15.08
EPS
-0.753
Volume
23,198
Market Cap
27.25M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
303,819
P/E Ratio
-0.951
Beta
3.41
1-Year Change
-94.43%
Shares Outstanding
36,829,626
Next Earnings Date
Mar 15, 2023
What is your sentiment on Codiak?
or
Market is currently closed. Voting is open during market hours.

Codiak BioSciences Inc News

Codiak BioSciences Inc Company Profile

Codiak BioSciences Inc Company Profile

Employees
102

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell
  • Sorry, I wouldnt touch this above 3. Ridiculously overpriced.
    0